Steven Michael Blum, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Adenomatous Polyposis Coli | 1 | 2021 | 224 | 0.720 |
Why?
|
| Posterior Leukoencephalopathy Syndrome | 1 | 2018 | 53 | 0.600 |
Why?
|
| Prostatic Hyperplasia | 1 | 2018 | 523 | 0.470 |
Why?
|
| Colonic Neoplasms | 1 | 2021 | 2541 | 0.350 |
Why?
|
| Drug Compounding | 2 | 2020 | 242 | 0.210 |
Why?
|
| Colorectal Neoplasms | 1 | 2021 | 6773 | 0.200 |
Why?
|
| Pharmaceutic Aids | 1 | 2020 | 6 | 0.200 |
Why?
|
| Bile Acids and Salts | 1 | 2022 | 367 | 0.190 |
Why?
|
| Neoplasms | 3 | 2023 | 21683 | 0.180 |
Why?
|
| Microsatellite Repeats | 1 | 2021 | 802 | 0.170 |
Why?
|
| Exosomes | 1 | 2023 | 417 | 0.170 |
Why?
|
| Melanoma | 3 | 2022 | 5510 | 0.170 |
Why?
|
| Microsatellite Instability | 1 | 2021 | 684 | 0.160 |
Why?
|
| Hypertension | 1 | 2018 | 8480 | 0.150 |
Why?
|
| Cardiology Service, Hospital | 1 | 2019 | 246 | 0.150 |
Why?
|
| Immunity | 1 | 2023 | 1012 | 0.150 |
Why?
|
| Hydronephrosis | 1 | 2018 | 269 | 0.140 |
Why?
|
| Neoplasms, Second Primary | 1 | 2022 | 1061 | 0.120 |
Why?
|
| Stomach Neoplasms | 1 | 2023 | 1333 | 0.120 |
Why?
|
| Leukocyte Count | 1 | 2018 | 1588 | 0.120 |
Why?
|
| Prescription Drugs | 1 | 2020 | 595 | 0.110 |
Why?
|
| Receptor, Notch1 | 1 | 2016 | 502 | 0.110 |
Why?
|
| Colitis | 1 | 2020 | 1170 | 0.100 |
Why?
|
| Patient Admission | 1 | 2019 | 1380 | 0.100 |
Why?
|
| Brain | 1 | 2018 | 26385 | 0.100 |
Why?
|
| Tumor Microenvironment | 1 | 2023 | 3586 | 0.100 |
Why?
|
| Pharmaceutical Preparations | 1 | 2019 | 1071 | 0.090 |
Why?
|
| Immunotherapy | 2 | 2022 | 4445 | 0.080 |
Why?
|
| Academic Medical Centers | 1 | 2019 | 2759 | 0.080 |
Why?
|
| MicroRNAs | 1 | 2023 | 3752 | 0.080 |
Why?
|
| Vitamin D | 1 | 2020 | 3223 | 0.070 |
Why?
|
| Clinical Competence | 1 | 2020 | 4687 | 0.060 |
Why?
|
| Healthcare Disparities | 1 | 2019 | 3158 | 0.060 |
Why?
|
| Transcription Factors | 1 | 2022 | 12208 | 0.050 |
Why?
|
| Diagnosis, Differential | 1 | 2018 | 12959 | 0.050 |
Why?
|
| Lactate Dehydrogenases | 1 | 2022 | 26 | 0.050 |
Why?
|
| Health Services Accessibility | 1 | 2019 | 5137 | 0.050 |
Why?
|
| Humans | 14 | 2023 | 744343 | 0.050 |
Why?
|
| Ascites | 1 | 2023 | 344 | 0.050 |
Why?
|
| Excipients | 1 | 2019 | 96 | 0.040 |
Why?
|
| Young Adult | 2 | 2022 | 56430 | 0.040 |
Why?
|
| Mutation | 1 | 2021 | 29786 | 0.040 |
Why?
|
| Feces | 1 | 2022 | 1401 | 0.040 |
Why?
|
| raf Kinases | 1 | 2016 | 122 | 0.030 |
Why?
|
| Heart Failure | 1 | 2019 | 10900 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2018 | 20129 | 0.030 |
Why?
|
| History, 21st Century | 1 | 2020 | 1534 | 0.030 |
Why?
|
| Cell Line, Tumor | 2 | 2023 | 16689 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2016 | 23403 | 0.030 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2016 | 584 | 0.030 |
Why?
|
| History, 20th Century | 1 | 2020 | 2740 | 0.030 |
Why?
|
| Lymphocytes | 1 | 2020 | 2617 | 0.030 |
Why?
|
| Aged | 3 | 2020 | 163280 | 0.030 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2016 | 713 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2016 | 1285 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2019 | 3913 | 0.020 |
Why?
|
| ras Proteins | 1 | 2016 | 1060 | 0.020 |
Why?
|
| Drug Prescriptions | 1 | 2020 | 1637 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2016 | 987 | 0.020 |
Why?
|
| Male | 5 | 2021 | 350118 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2018 | 35421 | 0.020 |
Why?
|
| Risk | 1 | 2023 | 9687 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2016 | 1915 | 0.020 |
Why?
|
| Female | 4 | 2021 | 380194 | 0.020 |
Why?
|
| Inpatients | 1 | 2019 | 2518 | 0.020 |
Why?
|
| Health Status Disparities | 1 | 2019 | 1797 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2016 | 2503 | 0.020 |
Why?
|
| Neutrophils | 1 | 2020 | 3719 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 2016 | 2969 | 0.020 |
Why?
|
| Boston | 1 | 2019 | 9313 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2016 | 4851 | 0.020 |
Why?
|
| Patient Readmission | 1 | 2019 | 3114 | 0.020 |
Why?
|
| Incidence | 1 | 2023 | 20947 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2022 | 12072 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2021 | 63114 | 0.010 |
Why?
|
| Gene Expression | 1 | 2016 | 7799 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2020 | 9274 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2016 | 11366 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2022 | 77449 | 0.010 |
Why?
|
| Middle Aged | 3 | 2021 | 213383 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2016 | 9438 | 0.010 |
Why?
|
| Disease Progression | 1 | 2016 | 13284 | 0.010 |
Why?
|
| Phenotype | 1 | 2016 | 16365 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2019 | 23338 | 0.010 |
Why?
|
| Time Factors | 1 | 2019 | 40075 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2016 | 18029 | 0.010 |
Why?
|
| Animals | 2 | 2019 | 168757 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 57776 | 0.010 |
Why?
|
| Risk Factors | 1 | 2019 | 72290 | 0.010 |
Why?
|
| Mice | 1 | 2016 | 81183 | 0.010 |
Why?
|
| Adult | 1 | 2022 | 214055 | 0.010 |
Why?
|